People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Illustris Pharmaceuticals Inc. | — | Biotechnology | Series A | $5.0M | $180.8M | 2016 |
Mark Prygocki at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Prygocki on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Siak Khim Tan | 1 | 2 |
| Andrew Khim Hirschberg | 1 | 1 |
| Jonah Khim Shacknai | 1 | 1 |
| Jaehoon M. Lee | 1 | 1 |
| Jacob M. Waugh | 1 | 1 |
| Gloria M. Vasquez | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.